Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Tuberculosis Diagnostics Market, by End Use
1.4.2 North America Tuberculosis Diagnostics Market, by Type
1.4.3 North America Tuberculosis Diagnostics Market, by Country
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.2.3 Market Opportunities
3.2.4 Market Challenges
3.3 Porter Five Forces Analysis
Chapter 4. North America Tuberculosis Diagnostics Market by End Use
4.1 North America Diagnostic Laboratories Market by Country
4.2 North America Hospitals & Clinics Market by Country
4.3 North America Others Market by Country
Chapter 5. North America Tuberculosis Diagnostics Market by Type
5.1 North America Detection of Latent Infection (Skin Test & IGRA) Market by Country
5.2 North America Phage Assay Market by Country
5.3 North America Detection of Drug Resistance (DST) Market by Country
5.4 North America Nucleic Acid Testing Market by Country
5.5 North America Radiographic Method Market by Country
5.6 North America Cytokine Detection Assay Market by Country
5.7 North America Diagnostic Laboratory Methods Market by Country
5.8 North America Other Methods Market by Country
Chapter 6. North America Tuberculosis Diagnostics Market by Country
6.1 US Tuberculosis Diagnostics Market
6.1.1 US Tuberculosis Diagnostics Market by End Use
6.1.2 US Tuberculosis Diagnostics Market by Type
6.2 Canada Tuberculosis Diagnostics Market
6.2.1 Canada Tuberculosis Diagnostics Market by End Use
6.2.2 Canada Tuberculosis Diagnostics Market by Type
6.3 Mexico Tuberculosis Diagnostics Market
6.3.1 Mexico Tuberculosis Diagnostics Market by End Use
6.3.2 Mexico Tuberculosis Diagnostics Market by Type
6.4 Rest of North America Tuberculosis Diagnostics Market
6.4.1 Rest of North America Tuberculosis Diagnostics Market by End Use
6.4.2 Rest of North America Tuberculosis Diagnostics Market by Type
Chapter 7. Company Profiles
7.1 Abbott Laboratories
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Segmental and Regional Analysis
7.1.4 Research & Development Expense
7.1.5 SWOT Analysis
7.2 Qiagen N.V.
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Regional Analysis
7.2.4 Research & Development Expenses
7.2.5 Recent strategies and developments:
7.2.5.1 Product Launches and Product Expansions:
7.2.6 SWOT Analysis
7.3 Thermo Fisher Scientific, Inc.
7.3.1 Company Overview
7.3.2 Financial Analysis
7.3.3 Segmental and Regional Analysis
7.3.4 Research & Development Expenses
7.3.5 Recent strategies and developments:
7.3.5.1 Product Launches and Product Expansions:
7.3.6 SWOT Analysis
7.4 Becton, Dickinson, and Company
7.4.1 Company Overview
7.4.2 Financial Analysis
7.4.3 Segmental and Regional Analysis
7.4.4 Research & Development Expense
7.4.5 Recent strategies and developments:
7.4.5.1 Partnerships, Collaborations, and Agreements:
7.4.6 SWOT Analysis
7.5 F. Hoffmann-La Roche Ltd.
7.5.1 Company Overview
7.5.2 Financial Analysis
7.5.3 Segmental and Regional Analysis
7.5.4 Research & Development Expense
7.5.5 Recent strategies and developments:
7.5.5.1 Acquisition and Mergers:
7.5.6 SWOT Analysis
7.6 Hologic, Inc.
7.6.1 Company Overview
7.6.2 Financial Analysis
7.6.3 Segmental and Regional Analysis
7.6.4 Research & Development Expenses
7.6.5 SWOT Analysis
7.7 Danaher Corporation
7.7.1 Company Overview
7.7.2 Financial Analysis
7.7.3 Segmental and Regional Analysis
7.7.4 Research & Development Expense
7.7.5 SWOT Analysis
7.8 DiaSorin S.p.A.
7.8.1 Company Overview
7.8.2 Financial Analysis
7.8.3 Regional Analysis
7.8.4 Research & Development Expenses
7.8.5 SWOT Analysis
7.9 Bruker Corporation
7.9.1 Company Overview
7.9.2 Financial Analysis
7.9.3 Segmental and Regional Analysis
7.9.4 Research & Development Expense
7.9.5 SWOT Analysis
7.10. Revvity, Inc.
7.10.1 Company Overview
7.10.2 Financial Analysis
7.10.3 Segmental and Regional Analysis
7.10.4 Research & Development Expenses
7.10.5 SWOT Analysis
Unique Offerings 